Position in PLRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,085,896
-$393,811 QoQ
Shares Held
861,823
-28.9% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. PLRX ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in PLRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,085,896 | 861,823 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,479,707 | 1,212,875 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,153,123 | 2,130,489 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $2,271,781 | 1,958,433 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $649,479 | 481,097 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,597,793 | 197,251 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $551,665 | 49,212 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $528,791 | 49,190 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $869,086 | 58,328 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,550,088 | 85,593 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,419,209 | 81,846 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,326,328 | 73,197 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $564,638 | 21,227 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $289,157 | 14,959 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $772,323 | 36,971 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,703 | 1,586 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $110,441 | 15,755 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $726,785 | 53,836 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $279,666 | 16,568 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $382,053 | 13,120 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,167,706 | 29,690 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $106,238 | 4,676 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $87,949 | 3,883 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||